
Phase I/II study of single-agent bortezomib for the treatment of patients with myelofibrosis. Clinical and biological effects of proteasome inhibition
Giovanni Barosi, Elisabetta Gattoni, Paola Guglielmelli, Rita Campanelli, Fabio Facchetti, Simona Fisogni, Judith Goldberg, Roberto Marchioli, Ronald Hoffman, Alessandro M. VannucchiVolume:
85
Année:
2010
Langue:
english
Pages:
4
DOI:
10.1002/ajh.21754
Fichier:
PDF, 2.26 MB
english, 2010